Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to -$47.0 million.

  • National Healthcare's Cash from Financing Activities fell 13373.74% to -$47.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$112.0 million, marking a year-over-year decrease of 20202.63%. This contributed to the annual value of $100.3 million for FY2024, which is 33585.38% up from last year.
  • As of Q3 2025, National Healthcare's Cash from Financing Activities stood at -$47.0 million, which was down 13373.74% from -$33.0 million recorded in Q2 2025.
  • National Healthcare's Cash from Financing Activities' 5-year high stood at $139.3 million during Q3 2024, with a 5-year trough of -$47.0 million in Q3 2025.
  • In the last 5 years, National Healthcare's Cash from Financing Activities had a median value of -$10.3 million in 2023 and averaged -$6.2 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 151873.73% in 2024, then crashed by 33398.13% in 2025.
  • Quarter analysis of 5 years shows National Healthcare's Cash from Financing Activities stood at -$9.5 million in 2021, then fell by 27.45% to -$12.1 million in 2022, then grew by 18.73% to -$9.8 million in 2023, then plummeted by 96.22% to -$19.3 million in 2024, then crashed by 143.59% to -$47.0 million in 2025.
  • Its Cash from Financing Activities stands at -$47.0 million for Q3 2025, versus -$33.0 million for Q2 2025 and -$12.7 million for Q1 2025.